Delivery Order SPE2DB22D3301-SPE2DB24FZ4ME

Award Date 9/16/24
Potential Completion Date 10/7/24
Potential Value $7.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of OPDIVO 240 MG/24 ML VIAL 24ML. The contract has a ceiling value of $14,906.79 and is a firm fixed-price delivery order, with an ultimate completion date of June 12, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of OPDIVO 240 MG/24 ML VIAL 24ML, a pharmaceutical product, with a ceiling value of $61,029.25. The contract is a firm fixed-price, non-set-aside delivery order with a period of performance through May 27, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of OPDIVO 240 MG/24 ML VIAL 24ML. The contract is a Firm Fixed Price delivery order with a ceiling value of $30,589.60 and a period of performance through August 28, 2024. This contract award is not associated with a set-aside designation. As a key supplier of pharmaceutical products and medical supplies to the U.S. federal government,...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $32,740.56, is for the delivery of OPDIVO 240 MG/24 ML VIAL 24ML, a pharmaceutical product. The contract has a firm fixed-price pricing type and an ultimate completion date of July 15, 2025. AmerisourceBergen Drug Corp is also the holder of a larger $999,999,999.00 Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OPDIVO 240 MG/24 ML VIAL 24ML, a specialty pharmaceutical product, with a ceiling value of $19,875.72 and a performance period through March 2025. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition....
This is a delivery order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of OPDIVO 240 MG/24 ML VIAL 24ML, a prescription medication, with a ceiling value of $24,844.65 and a completion date of July 8, 2025. The contract is a firm fixed price, non-set-aside award. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Opdivo 240 mg/24 ml vials. The contract has a ceiling value of $14,906.79 and a period of performance ending on June 18, 2025. It is a firm-fixed-price contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $20,371.90, is for the procurement of OPDIVO 240 MG/24 ML VIAL 24ML, a specialty pharmaceutical product. The contract has an ultimate completion date of January 12, 2024 and is a firm fixed-price delivery order. This award is part of a larger Indefinite Delivery Contract (IDC) valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of OPDIVO 240 MG/24 ML VIAL 24ML. The contract has a ceiling value of $7,647.40 and is a firm-fixed-price delivery order with an ultimate completion date of October 10, 2024. The contract is not set aside for any specific business type. As a major pharmaceutical distributor, AmerisourceBergen has been awarded numerous federal contracts and indefinite delivery contracts...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of OPDIVO 240 MG/24 ML VIAL 24ML, a prescription medication. The contract has a ceiling value of $59,627.16 and a performance period through May 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that AmerisourceBergen holds with DLA Troop Support Medical, which...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB24FZ4ME
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of OPDIVO 240 MG/24 ML VIAL 24ML. The contract has a total ceiling value of $7,647.40 and an ultimate completion date of October 7, 2024. It is a firm fixed-price contract and does not have any set-aside designations. Amerisourcebergen, through its Corporate Office division, will be responsible for delivering these pharmaceutical products to support the medical needs of military treatment facilities, veterans' hospitals, and other federal healthcare providers nationwide. This contract is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the company to efficiently provide a comprehensive range of medical commodities to the U.S. federal government.

Generated 12/16/24, 2:03 PM